QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol: |
Name o f Each Exchangeon Which Registered: | ||
one-half of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||||
PART I. FINANCIAL INFORMATION |
||||||
Item 1. |
1 |
|||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
Item 2. |
15 |
|||||
Item 3. |
19 |
|||||
Item 4. |
19 |
|||||
PART II. OTHER INFORMATION |
||||||
Item 1. |
20 |
|||||
Item 1A. |
20 |
|||||
Item 2. |
20 |
|||||
Item 3. |
20 |
|||||
Item 4. |
20 |
|||||
Item 5. |
20 |
|||||
Item 6. |
21 |
Item 1. |
Condensed Financial Statements |
Assets: |
||||
Current assets: |
||||
Cash |
$ | |||
|
|
|||
Total current assets |
||||
Deferred offering costs associated with proposed public offering |
||||
|
|
|||
Total assets |
$ |
|||
|
|
|||
Liabilities and Stockholder’s Deficit: |
||||
Current liabilities: |
||||
Accounts payable |
$ | |||
Accrued expenses |
||||
Franchise tax payable |
||||
Note payable—related party |
||||
|
|
|||
Total current liabilities |
||||
|
|
|||
Commitments and Contingencies |
||||
Stockholder’s Deficit: |
||||
Preferred stock, $ |
||||
Class A common stock, $ |
||||
Class B common stock, $ (1)(2) |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total stockholder’s deficit |
( |
) | ||
|
|
|||
Total Liabilities and Stockholder’s Deficit |
$ |
|||
|
|
(1) |
This number includes up to |
(2) |
Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of |
For The Three Months Ended September 30, 2021 |
For the period from April 16, 2021 (inception) through September 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Franchise tax expense |
||||||||
|
|
|
|
|||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Weighted average shares outstanding, basic and diluted (1)(2) |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
(1) |
This number excludes up to |
(2) |
Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of |
Common Stock |
Total |
|||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-In |
Accumulated |
Stockholder’s |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance—April 16, 2021 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Class B common stock to Sponsor (1)(2) |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance—June 30, 2021 (unaudited) |
( |
) |
||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance—September 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
This number includes up to |
(2) |
Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of |
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Changes in operating assets and liabilities: |
||||
Accounts payable |
||||
Franchise tax payable |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from issuance of Class B common stock to Sponsor |
||||
Net cash provided by financing activities |
||||
Net increase in cash |
||||
Cash—beginning of the period |
||||
Cash—end of the period |
$ |
|||
Supplemental disclosure of noncash activities: |
||||
Deferred offering costs included in accounts payable |
$ | |||
Deferred offering costs included in accrued expenses |
$ | |||
Deferred offering costs paid by related party under promissory note |
$ |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | |
• | |
• | if, and only if, the closing price of the Public Shares equals or exceeds $18.00 per share (as adjusted) for any |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per Public Share (as adjusted) for any |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B common stock resulted in the issuance of Class A common stock on a greater than one-to-one |
• | may subordinate the rights of holders of Class A common stock if shares of preferred stock are issued with rights senior to those afforded our Class A common stock; |
• | could cause a change in control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our Class A common stock and/or warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits. |
* | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
DMY TECHNOLOGY GROUP, INC. VI | ||
By: | /s/ Niccolo de Masi | |
Name: | Niccolo de Masi | |
Title: | Chief Executive Officer |
EXHIBIT 31.1
CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Niccolo de Masi, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of dMY Technology Group, Inc. VI; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) and 15d-15(e)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: November 15, 2021 | By: | /s/ Niccolo de Masi | ||||
Niccolo de Masi | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer and Principal Financial and Accounting Officer) |
EXHIBIT 31.2
CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Niccolo de Masi, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of dMY Technology Group, Inc. VI; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) and 15d-15(e)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls over financial reporting. |
Date: November 15, 2021 | By: |
/s/ Niccolo de Masi | ||||
Niccolo de Masi | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer and Principal Financial and Accounting Officer) |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of dMY Technology Group, Inc. VI (the Company) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Niccolo de Masi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 15, 2021
/s/ Niccolo de Masi | ||
Name: | Niccolo de Masi | |
Title: | Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of dMY Technology Group, Inc. VI (the Company) on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Niccolo de Masi, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 15, 2021 | ||||||
/s/ Niccolo de Masi | ||||||
Name: | Niccolo de Masi | |||||
Title: | Chief Executive Officer | |||||
(Principal Executive Officer and Principal Financial and Accounting Officer) |
Condensed Balance Sheets |
Sep. 30, 2021
USD ($)
|
|||||
---|---|---|---|---|---|---|
Current assets: | ||||||
Cash | $ 21,473 | |||||
Total current assets | 21,473 | |||||
Deferred offering costs associated with proposed public offering | 429,022 | |||||
Total Assets | 450,495 | |||||
Current liabilities: | ||||||
Accounts payable | 298,250 | |||||
Accrued expenses | 63,250 | |||||
Franchise tax payable | 91,886 | |||||
Note payable—related party | 74,991 | |||||
Total current liabilities | 528,377 | |||||
Commitments and Contingencies | ||||||
Stockholders' Equity: | ||||||
Preferred stock, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 | |||||
Additional paid-in capital | 24,396 | |||||
Accumulated deficit | (102,882) | |||||
Total stockholder's deficit | (77,882) | |||||
Total Liabilities and Stockholder's Deficit | 450,495 | |||||
Common Class A [Member] | ||||||
Stockholders' Equity: | ||||||
Common stock, value | 0 | |||||
Common Class B [Member] | ||||||
Stockholders' Equity: | ||||||
Common stock, value | $ 604 | [1],[2] | ||||
|
Condensed Balance Sheets (Parenthetical) - $ / shares |
Oct. 05, 2021 |
Oct. 04, 2021 |
Sep. 30, 2021 |
Sep. 24, 2021 |
---|---|---|---|---|
Preferred stock, par value | $ 0.0001 | |||
Preferred stock, shares authorized | 1,000,000 | |||
Preferred stock, shares issued | 0 | |||
Preferred stock, shares outstanding | 0 | |||
Common Class A [Member] | ||||
Common stock, par value | $ 0.0001 | |||
Common stock, shares authorized | 380,000,000 | |||
Common stock, shares issued | 0 | |||
Common stock, shares outstanding | 0 | |||
Common Class B [Member] | ||||
Common stock, par value | $ 0.0001 | |||
Common stock, shares authorized | 20,000,000 | |||
Common stock, shares issued | 6,037,500 | |||
Common stock, shares outstanding | 6,037,500 | 6,037,500 | ||
Share subject to forfeiture | 787,500 | |||
Common stock surrender shares | 2,156,250 |
Condensed Statements Of Operations - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2021 |
|||||
General and administrative expenses | $ 3,526 | $ 10,996 | ||||
Franchise tax expense | 89,946 | 91,886 | ||||
Net loss | $ (93,472) | $ (102,882) | ||||
Weighted average shares outstanding, basic and diluted | [1],[2] | 5,250,000 | 5,250,000 | |||
Basic and diluted net loss per share | $ (0.02) | $ (0.02) | ||||
|
Condensed Statements Of Operations (Parenthetical) - Common Class B [Member] - shares |
Oct. 05, 2021 |
Oct. 04, 2021 |
Sep. 30, 2021 |
Sep. 24, 2021 |
---|---|---|---|---|
Share subject to forfeiture | 787,500 | |||
Common stock surrender shares | 2,156,250 | |||
Common stock, shares outstanding | 6,037,500 | 6,037,500 |
Condensed Statements Of Changes In Stockholder's Equity (Deficit) - USD ($) |
Total |
Additional Paid-In Capital [Member] |
Accumulated Deficit [Member] |
Class A Shares [Member]
Common Stock [Member]
|
Class B Shares [Member]
Common Stock [Member]
|
||||
---|---|---|---|---|---|---|---|---|---|
Balance at Apr. 15, 2021 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||||
Balance (in shares) at Apr. 15, 2021 | 0 | 0 | |||||||
Issuance of Class B common stock to Sponsor | [1],[2] | 25,000 | 24,396 | $ 604 | |||||
Issuance of Class B common stock to Sponsor (share) | [1],[2] | 6,037,500 | |||||||
Net loss | (9,410) | (9,410) | |||||||
Balance at Jun. 30, 2021 | 15,590 | 24,396 | (9,410) | $ 0 | $ 604 | ||||
Balance (in shares) at Jun. 30, 2021 | 0 | 6,037,500 | |||||||
Balance at Apr. 15, 2021 | 0 | 0 | 0 | $ 0 | $ 0 | ||||
Balance (in shares) at Apr. 15, 2021 | 0 | 0 | |||||||
Net loss | (102,882) | ||||||||
Balance at Sep. 30, 2021 | (77,882) | 24,396 | (102,882) | $ 0 | $ 604 | ||||
Balance (in shares) at Sep. 30, 2021 | 0 | 6,037,500 | |||||||
Balance at Jun. 30, 2021 | 15,590 | 24,396 | (9,410) | $ 0 | $ 604 | ||||
Balance (in shares) at Jun. 30, 2021 | 0 | 6,037,500 | |||||||
Net loss | (93,472) | (93,472) | |||||||
Balance at Sep. 30, 2021 | $ (77,882) | $ 24,396 | $ (102,882) | $ 0 | $ 604 | ||||
Balance (in shares) at Sep. 30, 2021 | 0 | 6,037,500 | |||||||
|
Condensed Statements Of Changes In Stockholder's Equity (Deficit) (Parenthetical) - Common Class B [Member] - shares |
Oct. 05, 2021 |
Oct. 04, 2021 |
Sep. 30, 2021 |
Sep. 24, 2021 |
---|---|---|---|---|
Share subject to forfeiture | 787,500 | |||
Common stock surrender shares | 2,156,250 | |||
Common stock, shares outstanding | 6,037,500 | 6,037,500 |
Condensed Statement Of Cash Flows |
6 Months Ended |
---|---|
Sep. 30, 2021
USD ($)
| |
Cash Flows from Operating Activities: | |
Net loss | $ (102,882) |
Changes in operating assets and liabilities: | |
Accounts payable | 7,469 |
Franchise tax payable | 91,886 |
Net cash used in operating activities | (3,527) |
Cash Flows from Financing Activities: | |
Proceeds from issuance of Class B common stock to Sponsor | 25,000 |
Net cash provided by financing activities | 25,000 |
Net increase in cash | 21,473 |
Cash—beginning of the period | 0 |
Cash—end of the period | 21,473 |
Supplemental disclosure of noncash activities: | |
Deferred offering costs included in accounts payable | 290,781 |
Deferred offering costs included in accrued expenses | 63,250 |
Deferred offering costs paid by related party under promissory note | $ 74,991 |
Description of Organization and Business Operations |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Organization and Business Operations | Note 1 — Description of Organization and Business Operations dMY Technology Group, Inc. VI (the “Company”) is a blank check company incorporated in Delaware under the name TdMY Technology Group, Inc. on April 16, 2021. On July 7, 2021, the Company changed its name from TdMY Technology Group, Inc. to dMY Technology Group, Inc. VI. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of September 30, 2021, the Company had not commenced any operations. All activity for the period from April 16, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is dMY Sponsor VI, LLC, a Delaware limited liability company (the “Sponsor”). The registration statements for the Company’s Initial Public Offering were declared effective on September 30, 2021. On October 5, 2021, the Company consummated its Initial Public Offering of 24,150,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,150,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $241.5 million, and incurring offering costs of approximately $14.0 million, of which approximately $8.5 million and approximately $440,000 was for deferred underwriting commissions (see Note 5) and offering costs allocated to derivative warrant liabilities, respectively. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,830,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $6.8 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $241.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) located in the U.S. with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the Company’s outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.00 per Public Share plus pro rata interest earned in Trust Account). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to certain of the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Initial Stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Company’s amended and restated certificate of incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and any other holders of the Founder Shares immediately prior to the Initial Public Offering (the “Initial Stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have 18 months from the closing of the Initial Public Offering to consummate an initial Business Combination. However, if the Company anticipates that it may not be able to consummate its initial Business Combination within 18 months, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination once by an additional three months (for a total of 21 months to complete an initial Business Combination), provided that, the only way to extend the time available for the Company to consummate its initial Business Combination is for the Sponsor or its affiliates or designees, upon five days’ advance notice prior to the deadline, to deposit into the Trust Account an amount of $0.10 per Public Share, or approximately $2.0 million in the aggregate, on or prior to the date of the applicable deadline. Any such payments would be made in the form of a loan. Public Stockholders will not be offered the opportunity to vote on or redeem their Public Shares in connection with any such extension. If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering, being April 5, 2023, or 21 months from the closing of the Initial Public Offering, being July 5, 2023, if extended (the “Combination Period”), the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest (net of amounts withdrawn to fund working capital requirements, and/or to pay for the Company’s taxes (“permitted withdrawals”) and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders of the Company (including the right to receive further liquidating distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Initial Stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will hav e to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, and the results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Capital Resources As of September 30, 2021, the Company had $21,000 in its operating bank account and working capital deficit of approximately $507,000. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the cash contribution of $25,000 from the Sponsor to purchase Founder Shares (as defined in Note 4) and a loan from the Sponsor of approximately $75,000 under the Note (as defined in Note 4). The Company repaid the Note in full on October 4, 2021 in connection with the Initial Public Offering, at which time the Note was terminated. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, over-allotment, and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of September 30, 2021, there were no amounts outstanding under any Working Capital Loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
|
Basis of Presentation and Summary of Significant Accounting Policies |
6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 | |||||||||||||
Accounting Policies [Abstract] | |||||||||||||
Basis of Presentation and Summary of Significant Accounting Policies | Note 2 — Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from April 16, 2021 (inception) through September 30 and three months ended September 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021 or for any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the final prospectus and the Current Report on Form 8-K filed by the Company with the SEC on October 5, 2021 and October 12, 2021, respectively. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2021, the Company had no cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the balance sheet primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Deferred Offering Costs The Company complies with the requirements of FASB ASC 340-10-S99-1. Deferred non-operating expenses in the statement of operations. Offering costs associated with the Initial Public Offering are charged to stockholders’ equity upon the completion of the Initial Public Offering. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. There were no derivative financial instruments as of September 30, 2021. Net Loss Per Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. Weighted average shares at September 30, 2021 were reduced for the effect of an aggregate of 787,500 Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed de minimis as of September 30, 2021. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the period from April 6, 2021 (inception) through September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
|
Initial Public Offering |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Equity [Abstract] | |
Initial Public Offering | Note 3 — Initial Public Offering On October 5, 2021, the Company consummated its Initial Public Offering of 24,150,000 Units, including 3,150,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $241.5 million, and incurring offering costs of approximately $14.0 million, of which approximately $8.5 million and approximately $440,000 was for deferred underwriting commissions and offering costs allocated to derivative warrant liabilities, respectively. Each Unit consists of one Public Share, and
one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Public Share at a price of $11.50 per Public Share, subject to adjustment (see Note 7). |
Related Party Transactions |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4 — Related Party Transactions Founder Shares On April 27, 2021, the Sponsor purchased 7,187,500 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) for an aggregate purchase price of $25,000. Shares and the associated amounts have been retroactively restated to reflect: (i) the surrender of 2,156,250 Founder Shares for no consideration on September 24, 2021; and (ii) the 1:1.2 stock split on October 4, 2021, resulting in an aggregate of 6,037,500 Founder Shares outstanding. The Initial Stockholders agreed to forfeit up to 787,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters exercised their over-allotment option in full on October 5, 2021; thus, 787,500 Founder Shares were no longer subject to forfeiture . The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of th e initial Business Combination and (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of Public Shares equals or exceeds $12.00 per Public Share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lockup. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 6,830,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $6.8 million. Each Private Placement Warrant is exercisable for one whole Public Share at a price of $11.50 per Public Share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. Except as set forth below, the Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor or their permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Due From Related Party The Company advanced $60,000 to the Sponsor on October 2, 2021 and recorded such amount in due from related party. The Sponsor fully repaid this amount on October 11, 2021. Related Party Loans On April 16, 2021, the Sponsor agreed to loan the Company an aggregate of up to $200,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed approximately $75,000 under the Note and repaid the Note in full on October 4, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital.
|
Commitments and Contingencies |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 5 — Commitments and Contingencies Registration Rights and Stockholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $4.8 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional fee of $0.35 per unit, or approximately $8.5 million in the aggregate will be payable to certain of the underwriters for deferred underwriting commissions. The deferred fee will become payable to certain of the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
|
Stockholder's Equity |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Equity [Abstract] | |
Stockholder's Equity | Note 6 — Stockholder’s Equity Preferred Stock Class A Common Stock Class B Common Stock 6,037,500 Founder Shares outstanding, up to 787,500 Founder Shares were subject to forfeiture, to the Company by the Initial Stockholders for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Initial Stockholders would collectively own 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. The underwriter exercised its over-allotment option in full on October 5, 2021; thus, these 787,500 Founder Shares were no longer subject to forfeiture. Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Founder Shares will have the right to elect all of the Company’s directors prior to the consummation of the initial Business Combination. On any other matter submitted to a vote of the Company’s stockholders, holders of Founder Shares and holders of Public Shares will vote together as a single class, except as required by applicable law or stock exchange rule. The Founder Shares will automatically convert into Public Shares concurrently with or immediately following the consummation of the initial Business Combination on a
one-for-one as-converted basis, 20 % of the total number of Public Shares outstanding after such conversion (after giving effect to any redemptions of Public Shares by Public Stockholders), including the total number of Public Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Public Shares or equity-linked securities or rights exercisable for or convertible into Public Shares issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one |
Derivative Warrant Liabilities |
6 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 | |||||||||||||||||||||||||||||
Derivate Warrant Liabilities [Abstract] | |||||||||||||||||||||||||||||
Derivative Warrant Liabilities | Note 7 — Derivative Warrant Liabilities As of September 30, 2021, there were no warrants outstanding. In connection with the Initial Public Offering and subsequent over-allotment, the Company has 12,075,000 Public Warrants and 6,830,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Public Shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Public Shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Public Shares until the warrants expire or are redeemed. If a registration statement covering the Public Shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Public Shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Public Shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Public Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Public Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the Public Shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, except as set forth below, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per share of Public Shares equals or exceeds $18.00 .
Redemption of warrants when the price per share of Public Shares equals or exceeds $10.00.
The “fair market value” of Class A common stock shall mean the volume weighted average price of Public Shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Public Shares per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
|
Subsequent Events |
6 Months Ended |
---|---|
Sep. 30, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were issued. Based upon this review, except as noted above regarding the initial public offering, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the financial statements.
|
Basis of Presentation and Summary of Significant Accounting Policies (Policies) |
6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 | |||||||||||||
Accounting Policies [Abstract] | |||||||||||||
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from April 16, 2021 (inception) through September 30 and three months ended September 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021 or for any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the final prospectus and the Current Report on Form
8-K filed by the Company with the SEC on October 5, 2021 and October 12, 2021, respectively. |
||||||||||||
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
|
||||||||||||
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2021, the Company had no cash equivalents.
|
||||||||||||
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
|
||||||||||||
Financial Instruments | Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the balance sheet primarily due to their short-term nature.
|
||||||||||||
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
|
||||||||||||
Deferred Offering Costs | Deferred Offering Costs The Company complies with the requirements of FASB
ASC 340-10-S99-1. Deferred non-operating expenses in the statement of operations. Offering costs associated with the Initial Public Offering are charged to stockholders’ equity upon the completion of the Initial Public Offering. |
||||||||||||
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then
re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. There were no derivative financial instruments as of September 30, 2021. |
||||||||||||
Net Loss Per Share | Net Loss Per Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. Weighted average shares at September 30, 2021 were reduced for the effect of an aggregate of
787,500 |
||||||||||||
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed de minimis as of September 30, 2021. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No
amounts were accrued for the payment of interest and penalties for the period from April 6, 2021 (inception) through September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
||||||||||||
Recent Accounting Pronouncements | Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
|
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) |
6 Months Ended |
---|---|
Sep. 30, 2021
USD ($)
shares
| |
Significant Accounting Policies [Line Items] | |
Federal depository insurance coverage limit | $ 250,000 |
Cash equivalents | 0 |
Unrecognized tax benefits | 0 |
Unrecognized tax benefits accrued interest and penalties | $ 0 |
Common Class B [Member] | |
Significant Accounting Policies [Line Items] | |
Weighted average shares outstanding, basic and diluted | shares | 787,500 |
Initial Public Offering - Additional Information (Detail) |
Oct. 05, 2021
USD ($)
$ / shares
shares
|
---|---|
Subsequent Event [Member] | |
Initial Public Offering [Line Items] | |
Initial Public Offering, price per unit | $ / shares | $ 11.50 |
IPO [Member] | |
Initial Public Offering [Line Items] | |
Initial Public Offering, price per unit | $ / shares | $ 10.00 |
IPO [Member] | Subsequent Event [Member] | |
Initial Public Offering [Line Items] | |
Initial Public Offering, units | shares | 24,150,000 |
Initial Public Offering, price per unit | $ / shares | $ 10.00 |
Initial Public Offering, gross proceeds | $ 241,500,000 |
Initial Public Offering, offering costs | 8,500,000 |
Initial Public Offering, deferred underwriting commissions | 440,000 |
IPO [Member] | Maximum [Member] | Subsequent Event [Member] | |
Initial Public Offering [Line Items] | |
Initial Public Offering, offering costs | $ 14,000,000.0 |
Over-Allotment Option [Member] | Subsequent Event [Member] | |
Initial Public Offering [Line Items] | |
Initial Public Offering, units | shares | 3,150,000 |
Commitments and Contingencies - Additional Information (Detail) $ / shares in Units, $ in Millions |
6 Months Ended |
---|---|
Sep. 30, 2021
USD ($)
$ / shares
| |
Underwriting discount | $ / shares | $ 0.20 |
Underwriting discount aggregate amount | $ | $ 4.8 |
Additional fee per unit | $ / shares | $ 0.35 |
Deferred underwriting commissions in connection with the initial public offering | $ | $ 8.5 |
GR9URV,
M2R2=POPJ&4&G@&MVF?S:/&QV6];55 )2#08.(Q=DO^9X[8@\P="H ;@YP
MCP"X6P'HYH#N$:!;I5(O!_2. .ZH N#E .\(T/,J /T $#
M-A9.:1^\9R- -8?20$3;8T.P6BP^0"X99K>]9!:GJPTG@%69B-3Q5AL3T3">*U[K\UF
MV,YW_\?H>_"C+P"S-Q$/@]##OY,(O+_O503F703F@\HVI\Y!V68+L. T\>B3
MW;!&QPGQQMYIVM[;]4IRY)PL+#H?%N]%MR\EPZ!=DVGCN
#C.+
M<[L45Q$!8,: ",&\DV$=L -TKYHUHE.8SUJ\TW<-MK>*RIWQJ2AY,IAWTHCN
MX_=2G.QJ,Y?[+HCPH0ZUPJ($L^(*(YFN(!^N4C)0
G2Z(,">
M7;Q69Q?GZA??V4H]GR/*
);RS%_#:PNCOVV6('IWPSRN8YP?,
M\X1Y_C^E>QWE-Q>9+NGGGZZST^PM]4"3Z>KM'IKNT:_L/1>M$]T9%0+=TIVK
M*O1WWS@_-EX.)V=7PXO)9&\.3UD"N16F*W>^(.69V$8=#9)$1\XR;80?AI]8
MY26%4GQ*-@7)2!F#7HQ14."^;+W3TG)WE&1$'Y^R?7 -VL330L "&AXPI=HP
MQ9+)RQ@)6AKM=4W44.
,I2:U*A+G[8N?3KN
MTN%S#3EU5- .IPY+%^\ZEP+,:%\AC'@26P/GSU)IO^EH;J;0-^=,P#UR(Y=V
M$SU/9J^DCA>1*(RG$L>UOX$#2B(E!$KO<#9,R[?)R)>7*MPHY')8_8KL+T%G
MT#=(CL>8C\I.>Z8#T\@!43U 2#3\ACMCE=@']%P?LQM\ER@2=PU-P/E09(+^
MEL):FZHF&/H(B+@5(:83$A-**TFL=9,3-NCWH44CE#,FVHC\2\T,YFMMZ1^;
M-.9$GC^DH_K8S^24@C/ -\41%;A>WZ!1FH$/.^$?SCEC(6]N:A G9)")#$
MT=+QDI3#;2E\,.0_,IKO)?-G?^' .GXNTN:3/DH>2H^YSM\[[Z/.$H_O';6?
M !Z8Y?F]W1=;NZ
"N16I]AN^TR%3PF-*Y1 O!4Z,1D[(@66S4!?P02 C:G?BNL>SZ^[BB
M!OCEL*AUV"YX6T?]P$UF)+M#?$W%7 !/-5HXV .X!\XU9!>8K;"^N\3>%C,)
MG H5'+U?Z[_?/])T1H6K?/NV6/KX&/V#;PNF[ZZ8+>4 :J)@<5D0"QC2V&5&
M>WGM^_VHQ>"VJOGNNC(I W62$&V)3N:V9<8?'<7
'3/WDGP#N &+K<"D(/7MME08\S%\3ROF';;H 'R-P!D@K#5[H!XV_<
MZU@^-^'-K!O:-G-Q$6Q@> %[&M(#0C@#[]6S A#O;-?GG-W@KII[U;;#VIW
MQ84?5A@"I)*^0W]#X. 73P7UQ;+Q"9'VK(!4RGLV&HY*
ML="=+]>.B )'=J/2-)[V&^)/Q2D 1BJ$I,G(:@8*EYD;6I)$8[Y%"H>' AL0:X^JC
MH ?L4^'0KO"2!FX@3*TQ1R!DZ=*.H%'/ 6 R!6(\%H,>$TTL05P5P*=H^JMP
MS6D@)L :+X9E$PZG"BZGQ6DK+ME4\I6BWGZL3Q)K!09F/3L<-0,*QG91OO#AM-]WW^:QKU7H!ES6Y!8K7S:0WCAN^XQV.E Y E&R^.GH*0"6B5YGYC=XJ0"*AF(MN:_)[V&&GYUC_"KFV.#T:K/M)
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MD\WC*OU,*M8"Q!4MSQ^^7DB7OJCI@L26* U.0BZ18!TW2QG=K^^[' :Y8^$)G:' DJ&;"'=-Y#&XSS/2\<##W
MF933[+ZJ!YE(\X;HB3!GU@^9G8\LL*SF2+OAU2($.&Y)J6Y':0[-F.@=FW
MZR<3K&N@D +0!$GX^7-8.L%G>9Y< B#C<9^H//FVIB'_.K>
MU,^A6WD/@$0;73D%<<&M,BAN0#3PM2%_O(9]>@?I-3)(L1U2UVVZ X)0;983/,JL_9HN_9BT9Q76>
M!UK9VW6T 6!D@)VY"ES.'__SS,R!A&^ LM>/JIW;U'<[#U
M9OF/5RXY (0MK=]RQVTTD6\!28-8JA&=KC3)3GEQKDT_NUK->8+>WMM&A+?]I>$ D@7Z($@KRE[9W9SWW
M@K4_Q'&K)JH?N_,-/
>SRF"3WE<#.CK
MF7L5UA$3<&3^*9?Q_HJH;@5]Y%^AY=/(G(J\!)X'U_@<^SFY.K; ^WP+SM'P
MV)-"&H#Z$Y B_?YJ!3T '<<+^R UHZO@S/6CC##N/+Y9G6MRMWC(#N.X%=P4
M"*E7>(4Z:<#>J"M?\A0L7V^\9V"?01'@\2S_IZ^W'Z,U9[_ XI$RM<@V2SM?
M6M0E*M622_7N2&ZL9YC42!%SBKG3P?YI\*T;46Z5M6"STDDZC%&$XEH"%S,0
MF^T"T7!B$7MP/:#?8]+0@#RCV9AD?=N-^H&U[9D'!U+'!"2\+EF+;G&A9K:6FBM'@D
MC0F;L[RX
4V
M0C_2(HHFU%=B?D>\+8W^.1J.P[$QA>RAC%*(NF[!$Q; *)8KC])EQUM5<-PH
M"X[+^:IK4.!;EB[GE2YGI?S*C' A&62QTK=X,O2"1T,>UK."D!%#8X4.9>%]
M]^+U3/LLG1\ONEO>RN S7
:">&@Q&6)1)KFBF\-\R>JSYR;?\='9^?'*^=73VY
%35RB
MK?]9A!G<9#"!84*K7WWZ33,NPN#+1M'9WOJ3?]*+@O]56ADR#6ZX:T^BF+ 1
M;B2/UW'G_6$=D6<_Z'S8W64N+;A>A%)'N+S\[W=.*KY_HMDU[87VVL%?B@-<
MKJ*,20ITQNI&>$J1&79:./?!C1VEMU&6_I>2XP'$Z 7XCX*2,1Q7DS.>?8?0
ME_?]D:#R+7L0_IE\2LMW*.RVX RAM<#XWH6X(SRB]D(DF,2'A^,+TJZ(!V^!
M,=RH 7ER/-C
^M[W@(&%[^8B%38<#6*NA''VH';T*)F&O;[$_P;WG:0%_)C8X\Z,D<>F
M72JZ\3;*_&VYWG>1"K6T/?-N5_YMK^J7MU6_9.LI_Q967E+^78C<,O$(Q?!*
M?X&-"4=MZM+Y.!Y6?%QKK;2
HR^@U$2@7W_UG*,J$>H<(4,T!@:YF0JNFVQ2=,,#==VFOI
MTG[7=&F_O"[M9N=M=MY7N?,2^9N4.V3GZP_472QA.2I$#\*$FG]9$Q*!$D);
M@T0"!,:CKC+\JBFP\I:LZR9%/L[H6K(?*ZG6JB:(;UQ)XTI>B2O1+:A1<%,,
M,+RU1WN!VKGN0D? JI
V)80WG@BBA1F,F7=ZG63 4;)K+&_.@HGX0?$Z9
M,4ETFS>(L[&O==Y(1FQ/6*,&:9A,7VQZ'M_O"TNVIKZDJU1?V5-L(Z6N;_/
MP-VJY\&=+\=,(DYZ"VO1L3J+6,2':^3*E>$5^NI*&J=JZ0!OR@D;'?9138=D
M:/H^2S&2;/G,NN5!KN[.Q:;B%E'H(;0:F=\$4TG[7
3>QX:'IR:*
V8Y4:4"R@
M4)L',8\:]8[]'H;.QZYU57H07CRM_79T(8(2,%],@JN2S\=Q2=NZR\1F+)J(
MH!++L'82QI>07H]D',N9N36605Q1XB]>JZZNQVPF_$7-$3.NH,8"!G#$=J
M=NV;WE4I$I,I#E5OX8QN[9;M $T+ZL>M1OWXCN:US8/3\V_H@JMCHGUH6P/'
MOK;;3\YRN:8BYA45,I?7
M OD0L;#4J)ZQ2O7\@!W6CTFT 9P>M"^^QU@^9[WVO8PW N;6*A:'5OA_8
MCHU3MCZT;YN]&PN:;0?ZUU#]_>R\#,TA-#O].\?J0!8FP"C]$+_160V2LY-3
M5O@2/PSNF1!E<
M'L5BO(!XRN(:K$4I9YT<6 O:ACNEQB_!2(67V@KM1,U6U\ILM?H#7,@*;CK=
MYMW0JF4_GO5Y?8(E,&:N2B
';!IV[R-480BPS5O2KOF=:^D
MN^IR1OB4JCZ_U\+^-A.N ]7"U7>?Z25D[ .K9'P)NS;%0%YK&W3LG*MMCNAM (CFZY^:]35_
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M1\I]BMCK-?2.] FZ^W,J5@-!&+%Y.IX+-1B/*
>SIRCA:05^B?)IE-PDI5_-LWL.TRR+8+(>+E*X\<2M=Q-8VZ-Q$<:#+"-Y
M=D\8PBAY'KR&4
:CP)\$[!EV',V,5A8N_&1UP_E3+^CFA9)0"
MYM_)^#%\.R<)J%QJ2T1Z #!W1^#FK$E1^5/L"A'S)H%YD, OA@0DS-F4EHR7
M>4U!([006J@,/!44Y.Z(;(UV?>0&:FDA"\
"4;B&'3._456(&@>80U99%191KX,AM1[FN=X=UM*S<\1DX4%O*
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M\YJG&I^E1N_ 41)CV%0"!LQH4#8" A("&?;;98*;3IQ0UA## EA':_J
MR883$6G<3K QO":.V4'J/IN+YXK9V\<@IRM1/".2%<4SPAA0\7X.\CQ(2Z?.
M]>@ U:W/81\#U>?(*C:52TB(:N>\CT[MA..L"*=#5H13W!7AU,^^GJYG1<#G
M>/B*8.&Y8G:=*\*I]XIP.E'Q/%V-KY?I)LNWXO;O*D[I)3N9Z]P\K@:03D@3
MSUI_WRMI49,OG)Z(!E@.RH6X!W5>6E&C>#*MD%D V/5U_AWKT0#E+@D0>'M\
M]2>\B4+@G\.#VQ0OQ\"ZO=0H#YC/U[G=]FS
M[KVJE1H#T!UN78#@Q/P(Q